Vitamin K1 and progression of cardiovascular calcifications in hemodialysis patients: the VitaVasK randomized controlled trial.

Turgay SaritasSebastian ReinartzThilo KrügerMarkus KettelerOrfeas LiangosLaura LabriolaPeter StenvinkelChristoph KoppRalf WestenfeldPieter EvenepoelRobert SiepmannStephanie WiedRalf-Dieter HilgersLeon J SchurgersJürgen Floegenull null

Published in: Clinical kidney journal (2022)

Vitamin K1 intervention is a potent, safe and cost-effective approach to correct vitamin K deficiency and to potentially reduce cardiovascular calcification in this high-risk population.

Keyphrases

randomized controlled trial
study protocol
chronic kidney disease
systematic review
clinical trial
replacement therapy